Behnaz Taidi
- Immunology top 1%
- Oncology top 2%
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Ronald LevyDebra K. CzerwinskiEdgar G. EnglemanClaudia BenikeFrank J. HsuFrancesco FagnoniJohn M. TimmermanClemens B. Caspar
- Topics
- Immunotherapy and Immune Responses (8 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)Lymphoma Diagnosis and Treatment (4 papers)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Behnaz Taidi
12 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Immunology 2.0k
- Oncology 998
- Molecular Biology 786
- Radiology, Nuclear Medicine and Imaging 236
- Pathology and Forensic Medicine 232
Countries citing papers authored by Behnaz Taidi
This map shows the geographic impact of Behnaz Taidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behnaz Taidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behnaz Taidi more than expected).
Fields of papers citing papers by Behnaz Taidi
This network shows the impact of papers produced by Behnaz Taidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behnaz Taidi. The network helps show where Behnaz Taidi may publish in the future.
Co-authorship network of co-authors of Behnaz Taidi
This figure shows the co-authorship network connecting the top 25 collaborators of Behnaz Taidi. A scholar is included among the top collaborators of Behnaz Taidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behnaz Taidi. Behnaz Taidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 36 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 122 | |
| 6 | 2 | |
| 7 | 423 | |
| 8 | Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. | 141 |
| 9 | 27 | |
| 10 | Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cellsbreakdown → | 1514 |
| 11 | 22 | |
| 12 | 2 |
About Behnaz Taidi
Behnaz Taidi is a scholar working on Immunology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Immunology (2.0k citations), Oncology (998 citations) and Pathology and Forensic Medicine (232 citations). Behnaz Taidi has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Ronald Levy, Debra K. Czerwinski, Edgar G. Engleman, Claudia Benike, Frank J. Hsu, Francesco Fagnoni, John M. Timmerman, Clemens B. Caspar, Ranjani Rajapaksa and Thomas A. Davis. Their work appears in journals such as Nature Medicine, Blood and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.